Dr. Calvin Wu is a triple board-certified internist, pediatrician, and endocrinologist with a special interest in treating all forms of diabetes (including prediabetes and gestational diabetes). He is a passionate proponent of continuous glucose monitoring and other promising advances in diabetes technology/therapy, and has been championing a novel fully virtual multidisciplinary diabetes care model in his prior roles as the founding Lead Endocrinologist at Steady Health and Medical Director of Virtual Endocrinology at Carbon Health. He completed medical school at USC Keck School of Medicine, residency training at LAC+USC Medical Center, and an adult endocrinology fellowship at Harbor-UCLA Medical Center.

Professional Associations

• American Diabetes Association
• Endocrine Society

Innovation & Research

• virtual continuous care models for the management of cardiovascular-kidney-metabolic conditions

Selected Publications

• Wu CC, Cengiz A, Lawley SD. Less frequent dosing of GLP-1 receptor agonists as a viable weight maintenance strategy. Obesity (Silver Spring). 2025 Jul;33(7):1232-1236.
• Wu CC, Wu KC, Reddy S. Real-World Clinical Outcomes of a Virtual Integrated Diabetes Program for People with Type 1 and Type 2 Diabetes. Diabetes Technology and Obesity Medicine. 2025;1(1).
• Wu CC, Wu KC, José AS, Novin N. Virtual Endocrinology Care Emphasizing Data-Driven Insights and Continuous Engagement and Its Impact on Glycemic Outcomes in Patients With Uncontrolled Diabetes: A Real-world Retrospective Case Series. JMIR Diabetes. 2022 Mar 24;7(1):e30626.
• Wu CC, Econs MJ, DiMeglio LA, Insogna KL, Levine MA, Orchard PJ, Miller WP, Petryk A, Rush ET, Shoback DM, Ward LM, Polgreen LE. Diagnosis and Management of Osteopetrosis: Consensus Guidelines From the Osteopetrosis Working Group. J Clin Endocrinol Metab. 2017 Sep 1;102(9):3111-3123.